Molecular Cardiology Research Institute

Molecular Cardiology Research Institute
Name	Molecular Cardiology Research Institute
Established	1999
Director	Michael R. Rosen
Parent	Icahn School of Medicine at Mount Sinai
City	New York City
State	New York
Country	United States

Molecular Cardiology Research Institute. It is a premier, interdisciplinary research center dedicated to advancing the fundamental understanding of cardiovascular biology and disease. Founded at the Icahn School of Medicine at Mount Sinai in New York City, the institute integrates basic molecular science with translational clinical investigation. Its mission is to elucidate the cellular and genetic mechanisms underlying heart conditions to develop novel therapeutic strategies.

History and Establishment

The institute was formally established in 1999 under the leadership of founding director Michael R. Rosen, a renowned cardiologist and electrophysiologist. Its creation was driven by the vision to centralize and elevate cardiovascular research within the Mount Sinai Health System during a period of rapid expansion in molecular biology. The founding was supported by key figures within the Icahn School of Medicine at Mount Sinai, including then-dean Nathan Kase, aligning with a broader institutional commitment to translational science. This initiative built upon a longstanding legacy of cardiovascular excellence at the hospital, which traces its roots to the early 20th century work of physicians like Arthur M. Master of the Master's two-step test.

Research Focus and Scientific Programs

Core scientific programs are organized around several intersecting themes, including cardiac electrophysiology and arrhythmia mechanisms, heart failure and myocardial biology, vascular biology and atherosclerosis, and cardiac developmental genetics. A major focus involves investigating the role of ion channels, calcium handling proteins, and gap junctions in conditions like atrial fibrillation and sudden cardiac death. Researchers also explore signaling pathways involved in cardiac hypertrophy, fibrosis, and regeneration, often utilizing genetically engineered mouse models. The institute maintains strong programs in systems biology and bioinformatics to analyze complex datasets from genomic and proteomic studies.

Key Discoveries and Contributions

Investigators have made seminal contributions to the understanding of the molecular basis of cardiac rhythm disorders, including pioneering work on the role of the ryanodine receptor in catecholaminergic polymorphic ventricular tachycardia. Research has elucidated critical pathways in the progression of heart failure, such as maladaptive calcium/calmodulin-dependent protein kinase signaling. The institute has been instrumental in advancing knowledge of endothelial cell biology and its dysfunction in coronary artery disease. Its scientists have also identified novel genetic regulators of heart development and contributed to the foundational science behind emerging therapies like gene editing for inherited cardiomyopathies.

Facilities and Technological Resources

The institute occupies state-of-the-art laboratory space within the Leon and Norma Hess Center for Science and Medicine and other research buildings on the Upper East Side campus. It provides researchers with centralized core facilities for advanced microscopy, including confocal and super-resolution imaging, and a transgenic animal modeling core. A dedicated electrophysiology core offers patch-clamp rigs and optical mapping systems for functional studies. Computational resources are supported through partnerships with the Icahn Institute for Data Science and Genomic Technology, enabling large-scale genomic analysis and computational modeling of cardiac systems.

Collaborations and Affiliations

The institute maintains deep integrative ties with clinical departments, including the Mount Sinai Hospital's Cardiovascular Institute and the Zena and Michael A. Wiener Cardiovascular Institute. It actively collaborates with other research centers within the Icahn School of Medicine at Mount Sinai, such as the Mindich Child Health and Development Institute and the Diabetes, Obesity and Metabolism Institute. National partnerships include ongoing projects with the National Institutes of Health, the American Heart Association, and consortia like the Framingham Heart Study. International collaborations extend to institutions like the University of Oxford and Karolinska Institutet.

Notable Faculty and Leadership

The founding director, Michael R. Rosen, is a member of the National Academy of Medicine and a past president of the Heart Rhythm Society. Notable faculty have included Glenn I. Fishman, a leading expert in cardiac conduction, and Roger J. Hajjar, known for pioneering gene therapy approaches for heart failure. Current senior investigators include experts in vascular biology like Ann Marie Schmidt and translational scientists such as Stuart D. Katz. The institute has also trained numerous fellows who have advanced to leadership positions at academic medical centers across the United States and internationally.

Category:Medical and health organizations based in New York City Category:Cardiology research Category:Mount Sinai Health System